The oral SARS-CoV-2 3C-like protease inhibitor ensitrelvir fumaric acid helps speed up recovery time for COVID-19 symptoms in patients with mild-to-moderate infection, according to the phase III data from the phase II/III SCORPIO-SR study conducted in Asia.
A recent study recommends adjusting both loading dosing and maintenance dosing regimens of teicoplanin based on the renal function and serum albumin concentration of patients with methicillin-resistant staphylococcus aureus (MRSA) infection.
Being infected with COVID-19 may reduce the sexual function of cisgender women, while having long COVID can worsen the already impaired sexual function as compared to those who do not have long COVID, a study has found. However, the mechanisms as to why these effects occur remain unclear.
Bacterial respiratory tract infection normally occurs in infants requiring early intubation in the emergency department (ED) for viral bronchiolitis, according to a study. However, respiratory bacterial codetection appears to shorten the duration of mechanical ventilation (MV) and length of stay (LOS) of these patients in the intensive care unit (ICU).
Adults with inflammatory bowel disease (IBD) benefit from COVID-19 vaccination, with its protective effect lasting up to 52 weeks postvaccination even among vulnerable populations such as corticosteroid users and older individuals, according to a study.
Concomitant administration of vancomycin (VAN) and piperacillin/tazobactam (PTZ) appears to contribute to a heightened risk of acute kidney injury (AKI) in adult patients in the general ward, results of a study have shown. In addition, VAN+PTZ is associated with more severe AKI.
The risk of developing serious infections is much lower among patients with Crohn’s disease (CD) who showed response to adalimumab therapy than nonresponders, after accounting for disease severity, according to the results of a study presented at CCC 2024.